Ikarian Capital, LLC Q3 2023 Filing

Filed November 14, 2023

Portfolio Value

$831.4B

Holdings

107

Report Date

Q3 2023

Filing Type

13F-HR

All Holdings (107 positions)

#StockSharesValue% PortfolioType
101
ESPRESPERION THERAPEUTICS INC NE
1,737,636$1K0.00%
102
QUREUNIQURE NV
157,365$1K0.00%
103
VTGNVISTAGEN THERAPEUTICS INC
229,100$1K0.00%
104
AVROBIO INC
718,259$1K0.00%
105
NUVBNUVATION BIO INC
1,222,852$1K0.00%
106
MISTMILESTONE PHARMACEUTICALS IN
462,828$1K0.00%
107
BIVIBIOVIE INC
457,345$1K0.00%
PreviousPage 2 of 2